The Company also announced that Dr. Nasser Khan resigned from his role as Chief Operating Officer, effective November 3, 2025. Dr. Khan will continue to serve as an executive advisor through December 31, 2025. The Company has initiated a search for his replacement, and in the interim, Dr. Khan’s responsibilities are being assumed by other members of executive management.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare lowers FY25 adjusted EPS $2.35-$2.45 from $2.45-$2.65
- Acadia Healthcare taking ‘decisive action to drive improved performance’
- Acadia Healthcare sees FY25 EPS $2.35-$2.45, consensus $2.47
- Acadia Healthcare reports Q3 adjusted EPS 72c, consensus 66c
- ACHC Earnings Report this Week: Is It a Buy, Ahead of Earnings?